Matthew Elvey
3
2
Matthew Elvey has not written any posts yet.
Matthew Elvey has not written any posts yet.
I contacted the maintainer of the New York Times treatment tracker when her Information about Ivermectin was sorely (months) out of date. The interaction led me to conclude it’s not a reliable source. She promptly blocked me and didn’t respond and didn’t update it. I’m new here (or misplaced my credentials) so I won’t link to the tweet of the DM but it’s public. I’ve read all the primary source clinical trial studies on ivermectin for Covid. (including the one that just came out on 6/2. ). Either the reporter hasn’t read most of them or she’s part of the disinformation campaign.
I would say the strength of the evidence For the efficacy of ivermectin in treating in preventing Covid is greater than it was when I originally posted.
But it is less apparent. Pervasive censorship and malinformation campaigns mean people are more easily misled and have to do more and more work to have a clear understanding, It’s easier and easier to come to utterly invalid conclusions despite a substantial amount of research that is too superficial - E.g. rests on minimal assumptions of integrity of the peer review process and major institutions that it turns out one can prove are unwarranted. I would largely agree with the advice that JimRandomH gives, with... (read more)